240 related articles for article (PubMed ID: 26225830)
1. Angiotensin-(1-7) Suppresses Hepatocellular Carcinoma Growth and Angiogenesis via Complex Interactions of Angiotensin II Type 1 Receptor, Angiotensin II Type 2 Receptor and Mas Receptor.
Liu Y; Li B; Wang X; Li G; Shang R; Yang J; Wang J; Zhang M; Chen Y; Zhang Y; Zhang C; Hao P
Mol Med; 2015 Jul; 21(1):626-36. PubMed ID: 26225830
[TBL] [Abstract][Full Text] [Related]
2. Candesartan attenuates angiogenesis in hepatocellular carcinoma via downregulating AT1R/VEGF pathway.
Fan F; Tian C; Tao L; Wu H; Liu Z; Shen C; Jiang G; Lu Y
Biomed Pharmacother; 2016 Oct; 83():704-711. PubMed ID: 27470571
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Liu S; Mehta JL
Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo.
Du H; Liang Z; Zhang Y; Jie F; Li J; Fei Y; Huang Z; Pei N; Wang S; Li A; Chen B; Zhang Y; Sumners C; Li M; Li H
PLoS One; 2013; 8(12):e83754. PubMed ID: 24391821
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer.
Pei N; Mao Y; Wan P; Chen X; Li A; Chen H; Li J; Wan R; Zhang Y; Du H; Chen B; Jiang G; Xia M; Sumners C; Hu G; Gu D; Li H
J Exp Clin Cancer Res; 2017 Jun; 36(1):77. PubMed ID: 28599664
[TBL] [Abstract][Full Text] [Related]
7. The influence of TNF-α and Ang II on the proliferation, migration and invasion of HepG2 cells by regulating the expression of GRK2.
Xu ZW; Yan SX; Wu HX; Chen JY; Zhang Y; Li Y; Wei W
Cancer Chemother Pharmacol; 2017 Apr; 79(4):747-758. PubMed ID: 28315953
[TBL] [Abstract][Full Text] [Related]
8. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
10. Tanshindiol-C suppresses in vitro and in vivo hepatocellular cancer cell growth by inducing mitochondrial-mediated apoptosis, cell cycle arrest, inhibition of angiogenesis and modulation of key tumor-suppressive miRNAs.
Zhou P; Cheng Y; Liu F; Wu K; Qiu W; Wang S
J BUON; 2019; 24(2):622-627. PubMed ID: 31128015
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.
Nemoto W; Ogata Y; Nakagawasai O; Yaoita F; Tadano T; Tan-No K
Eur J Pain; 2014 Nov; 18(10):1471-9. PubMed ID: 24733750
[TBL] [Abstract][Full Text] [Related]
12. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
[TBL] [Abstract][Full Text] [Related]
13. Role of Mas receptor antagonist (A779) in renal hemodynamics in condition of blocked angiotensin II receptors in rats.
Mansoori A; Oryan S; Nematbakhsh M
Physiol Int; 2016 Mar; 103(1):13-20. PubMed ID: 27030624
[TBL] [Abstract][Full Text] [Related]
14. Effect of luteolin on gene expression in mouse H22 hepatoma cells.
Niu JX; Guo HP; Gan HM; Bao LD; Ren JJ
Genet Mol Res; 2015 Nov; 14(4):14448-56. PubMed ID: 26600503
[TBL] [Abstract][Full Text] [Related]
15. Role of two types of angiotensin II receptors in colorectal carcinoma progression.
Zhou L; Luo Y; Sato S; Tanabe E; Kitayoshi M; Fujiwara R; Sasaki T; Fujii K; Ohmori H; Kuniyasu H
Pathobiology; 2014; 81(4):169-75. PubMed ID: 25138435
[TBL] [Abstract][Full Text] [Related]
16. A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K/Akt and activation of p38 MAPK signaling pathway and displays antitumor activity in vivo.
Liang M; Liu J; Ji H; Chen M; Zhao Y; Li S; Zhang X; Li J
Tumour Biol; 2015 Sep; 36(9):7085-91. PubMed ID: 25874498
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
19. Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1-7)/MasR signaling in normal and hypertensive pregnancy.
Clark CR; Khalil RA
Biochem Pharmacol; 2024 Feb; 220():115963. PubMed ID: 38061417
[TBL] [Abstract][Full Text] [Related]
20. Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.
Chan LY; Leung JC; Tang SC; Choy CB; Lai KN
J Am Soc Nephrol; 2005 Aug; 16(8):2306-17. PubMed ID: 15930094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
